US Stock MarketDetailed Quotes

VINC Vincerx Pharma

Watchlist
  • 0.700
  • -0.020-2.72%
Close May 22 16:00 ET
  • 0.700
  • 0.0000.00%
Pre 04:21 ET
20.67MMarket Cap-393P/E (TTM)

Vincerx Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
40.89%-7.74M
32.13%-40.45M
41.96%-8.02M
55.32%-6.65M
20.08%-12.7M
12.88%-13.09M
-78.44%-59.6M
-20.29%-13.82M
-44.33%-14.87M
-94.34%-15.89M
Net income from continuing operations
15.16%-12.43M
36.24%-40.16M
56.04%-4.95M
42.44%-9.72M
41.14%-10.84M
10.80%-14.65M
-60.24%-62.98M
-73.98%-11.26M
31.17%-16.88M
-805.65%-18.42M
Operating gains losses
29,011.11%5.2M
100.75%47K
90.32%59K
-241.77%-112K
109.82%118K
99.65%-18K
73.02%-6.3M
100.28%31K
-98.80%79K
92.17%-1.2M
Depreciation and amortization
71.43%264K
-2.56%915K
7.05%258K
7.63%254K
7.33%249K
-33.04%154K
176.18%939K
-29.74%241K
391.67%236K
992.31%232K
Change In working capital
-448.27%-1.31M
-310.88%-4.19M
-119.31%-3.82M
411.28%1.68M
-1,814.08%-2.43M
-66.49%375K
-118.19%-1.02M
-13,484.62%-1.74M
-136.28%-541K
-94.55%142K
-Change in receivables
52.01%-131K
64.00%328K
-95.50%9K
----
----
---273K
--200K
--200K
----
----
-Change in prepaid assets
14.85%-625K
138.89%1.23M
102.61%58K
742.80%2.11M
-551.11%-203K
40.52%-734K
-403.36%-3.16M
-1,368.00%-2.22M
-41.86%250K
-73.68%45K
-Change in payables and accrued expense
-113.70%-211K
-397.93%-3.74M
-292.47%-3.34M
61.87%-233K
-14,325.00%-1.71M
-43.03%1.54M
-79.87%1.25M
-388.51%-850K
-122.79%-611K
-99.49%12K
-Change in other current assets
---56K
-178.50%-1.08M
-120.87%-284K
---250K
-341.33%-543K
--0
187.33%1.37M
1,196.19%1.36M
--0
581.82%225K
-Change in other current liabilities
-79.11%-283K
-26.56%-934K
-13.36%-263K
-12.61%-259K
-81.43%-254K
-16.18%-158K
-720.00%-738K
-149.46%-232K
-369.39%-230K
-618.52%-140K
-Change in other working capital
----
----
----
----
----
----
--50K
--0
----
----
Cash from discontinued investing activities
Operating cash flow
40.89%-7.74M
32.13%-40.45M
41.96%-8.02M
55.32%-6.65M
20.08%-12.7M
12.88%-13.09M
-78.44%-59.6M
-20.29%-13.82M
-44.33%-14.87M
-94.34%-15.89M
Investing cash flow
Cash flow from continuing investing activities
0
202.27%41.5M
128.21%5.75M
174.58%15.06M
14.8M
5.89M
-671.74%-40.58M
-254,687.50%-20.38M
-91,695.45%-20.2M
0
Net investment purchase and sale
--0
202.27%41.5M
128.21%5.75M
174.58%15.06M
--14.8M
--5.89M
---40.58M
---20.38M
---20.2M
--0
Cash from discontinued investing activities
Investing cash flow
--0
202.27%41.5M
128.21%5.75M
174.58%15.06M
--14.8M
--5.89M
-671.74%-40.58M
-254,687.50%-20.38M
-91,695.45%-20.2M
--0
Financing cash flow
Cash flow from continuing financing activities
66.67%5K
-59.29%114K
-52.63%18K
0
-61.57%93K
3K
-99.68%280K
-86.57%38K
0
242K
Proceeds from stock option exercised by employees
66.67%5K
-59.29%114K
-52.63%18K
--0
-61.57%93K
--3K
-99.32%280K
-89.17%38K
--0
--242K
Cash from discontinued financing activities
Financing cash flow
66.67%5K
-59.29%114K
-52.63%18K
--0
-61.57%93K
--3K
-99.68%280K
-86.57%38K
--0
--242K
Net cash flow
Beginning cash position
9.55%12.85M
-89.48%11.73M
-66.97%15.15M
-91.66%6.75M
-95.28%4.56M
-89.48%11.73M
80.55%111.56M
-62.65%45.87M
-5.49%80.92M
80.96%96.55M
Current changes in cash
-7.36%-7.73M
101.16%1.16M
93.41%-2.25M
124.00%8.42M
114.06%2.2M
52.06%-7.2M
-300.63%-99.9M
-204.72%-34.16M
-194.33%-35.07M
-148.48%-15.65M
Effect of exchange rate changes
140.00%72K
-156.34%-40K
-259.26%-43K
-213.33%-17K
-183.33%-10K
76.47%30K
438.10%71K
228.57%27K
--15K
--12K
End cash Position
13.88%5.19M
9.55%12.85M
9.55%12.85M
-66.97%15.15M
-91.66%6.75M
-95.28%4.56M
-89.48%11.73M
-89.48%11.73M
-62.65%45.87M
-5.49%80.92M
Free cash flow
40.89%-7.74M
32.13%-40.45M
41.96%-8.02M
55.32%-6.65M
20.08%-12.7M
12.88%-13.09M
-54.17%-59.6M
-20.21%-13.82M
-44.02%-14.87M
-89.06%-15.89M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 40.89%-7.74M32.13%-40.45M41.96%-8.02M55.32%-6.65M20.08%-12.7M12.88%-13.09M-78.44%-59.6M-20.29%-13.82M-44.33%-14.87M-94.34%-15.89M
Net income from continuing operations 15.16%-12.43M36.24%-40.16M56.04%-4.95M42.44%-9.72M41.14%-10.84M10.80%-14.65M-60.24%-62.98M-73.98%-11.26M31.17%-16.88M-805.65%-18.42M
Operating gains losses 29,011.11%5.2M100.75%47K90.32%59K-241.77%-112K109.82%118K99.65%-18K73.02%-6.3M100.28%31K-98.80%79K92.17%-1.2M
Depreciation and amortization 71.43%264K-2.56%915K7.05%258K7.63%254K7.33%249K-33.04%154K176.18%939K-29.74%241K391.67%236K992.31%232K
Change In working capital -448.27%-1.31M-310.88%-4.19M-119.31%-3.82M411.28%1.68M-1,814.08%-2.43M-66.49%375K-118.19%-1.02M-13,484.62%-1.74M-136.28%-541K-94.55%142K
-Change in receivables 52.01%-131K64.00%328K-95.50%9K-----------273K--200K--200K--------
-Change in prepaid assets 14.85%-625K138.89%1.23M102.61%58K742.80%2.11M-551.11%-203K40.52%-734K-403.36%-3.16M-1,368.00%-2.22M-41.86%250K-73.68%45K
-Change in payables and accrued expense -113.70%-211K-397.93%-3.74M-292.47%-3.34M61.87%-233K-14,325.00%-1.71M-43.03%1.54M-79.87%1.25M-388.51%-850K-122.79%-611K-99.49%12K
-Change in other current assets ---56K-178.50%-1.08M-120.87%-284K---250K-341.33%-543K--0187.33%1.37M1,196.19%1.36M--0581.82%225K
-Change in other current liabilities -79.11%-283K-26.56%-934K-13.36%-263K-12.61%-259K-81.43%-254K-16.18%-158K-720.00%-738K-149.46%-232K-369.39%-230K-618.52%-140K
-Change in other working capital --------------------------50K--0--------
Cash from discontinued investing activities
Operating cash flow 40.89%-7.74M32.13%-40.45M41.96%-8.02M55.32%-6.65M20.08%-12.7M12.88%-13.09M-78.44%-59.6M-20.29%-13.82M-44.33%-14.87M-94.34%-15.89M
Investing cash flow
Cash flow from continuing investing activities 0202.27%41.5M128.21%5.75M174.58%15.06M14.8M5.89M-671.74%-40.58M-254,687.50%-20.38M-91,695.45%-20.2M0
Net investment purchase and sale --0202.27%41.5M128.21%5.75M174.58%15.06M--14.8M--5.89M---40.58M---20.38M---20.2M--0
Cash from discontinued investing activities
Investing cash flow --0202.27%41.5M128.21%5.75M174.58%15.06M--14.8M--5.89M-671.74%-40.58M-254,687.50%-20.38M-91,695.45%-20.2M--0
Financing cash flow
Cash flow from continuing financing activities 66.67%5K-59.29%114K-52.63%18K0-61.57%93K3K-99.68%280K-86.57%38K0242K
Proceeds from stock option exercised by employees 66.67%5K-59.29%114K-52.63%18K--0-61.57%93K--3K-99.32%280K-89.17%38K--0--242K
Cash from discontinued financing activities
Financing cash flow 66.67%5K-59.29%114K-52.63%18K--0-61.57%93K--3K-99.68%280K-86.57%38K--0--242K
Net cash flow
Beginning cash position 9.55%12.85M-89.48%11.73M-66.97%15.15M-91.66%6.75M-95.28%4.56M-89.48%11.73M80.55%111.56M-62.65%45.87M-5.49%80.92M80.96%96.55M
Current changes in cash -7.36%-7.73M101.16%1.16M93.41%-2.25M124.00%8.42M114.06%2.2M52.06%-7.2M-300.63%-99.9M-204.72%-34.16M-194.33%-35.07M-148.48%-15.65M
Effect of exchange rate changes 140.00%72K-156.34%-40K-259.26%-43K-213.33%-17K-183.33%-10K76.47%30K438.10%71K228.57%27K--15K--12K
End cash Position 13.88%5.19M9.55%12.85M9.55%12.85M-66.97%15.15M-91.66%6.75M-95.28%4.56M-89.48%11.73M-89.48%11.73M-62.65%45.87M-5.49%80.92M
Free cash flow 40.89%-7.74M32.13%-40.45M41.96%-8.02M55.32%-6.65M20.08%-12.7M12.88%-13.09M-54.17%-59.6M-20.21%-13.82M-44.02%-14.87M-89.06%-15.89M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg